Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on ProMedicus.
RELATED STOCKHEAD STORIES
Experts
After scaring everyone in 2022 it looks like ASX health stocks will have a pulse in 2023
News
ASX Large Caps: Local shares cruise to a 5-month high; BNPL stocks surge
Health & Biotech
ScoPo’s Powerplays: Is it time to fill the Christmas stocking early with some ASX health stocks?
Health & Biotech
ASX Health Stocks: HITIQ signs renewed deal with English cricket to manage concussion injuries
Experts
ScoPo’s Powerplays: Reporting season positive as ASX health stocks head in right direction
Experts
ScoPo’s Powerplays: Business as usual for ASX health stocks plus… some good news!
Experts
ScoPo’s Powerplays: Who stands out in the enterprise imaging sector?
Health & Biotech
ASX Health Stocks: Alterity is set to launch Phase 2 clinical trial on Multiple System Atrophy
Explainers
Price Earnings Ratio: How you should (or shouldn’t) use it to find undervalued stocks
Health & Biotech
5 thematics to bring the Australian life sciences sector back in from the cold
Health & Biotech
ASX Health Stocks: Pro Medicus bags $32m deal, Kazia shows promise in child cancer drug
Experts
ScoPo’s Powerplays: Who’s pulling for a health sector recovery?
Experts
ScoPo’s Powerplays: Who’s staying afloat in the inflation storm?
Experts
ScoPo’s Powerplays: Who’s making a gritty comeback?
Experts
SocPo’s Powerplays: A few healthcare gems among the carnage
Experts
ScoPo’s Powerplays: Healthcare’s game is off, but a comeback is possible
Health & Biotech